BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Did SAGE Therapeutics Just Break the CNS Curse?

  With Sage’s positive data, we may be embarking on a neuroscience renaissance.

  December 8, 2017

   · 

  3 min read

   · 

  Karl Thiel
• 

  Business

  What You Need to Know About Relay Therapeutics

  Based in Cambridge, MA and founded in February 2016, Relay Therapeutics focuses on developing therapeutics based on protein motion.

  December 8, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Bio NC

  Top Countries With the Highest Paid Salaries for Scientists

  It’s no secret that the life sciences are increasingly international.

  December 8, 2017

   · 

  5 min read

   · 

  Mark Terry
• Biotech Bay

  Rigel Pharma Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

  Rigel today announced that on December 4, 2017 the Compensation Committee of Rigel’s Board of Directors approved the grant of inducement stock options to purchase an aggregate of 60,000 shares of common stock to one new employee.

  December 8, 2017

   · 

  2 min read
• ANGLE plc Announces Parsortix Potential in Metastatic Breast Cancer

  ANGLE plc is delighted to announce that the University of Southern California (USC) Norris Comprehensive Cancer Center yesterday presented results of extensive work with ANGLE’s Parsortix system at the San Antonio Breast Cancer Symposium (SABCS).

  December 8, 2017

   · 

  8 min read
• Drug Development

  ARMO BioSciences Presents Efficacy Data From its Phase Ib Trial in Patients With Metastatic Renal Cell Carcinoma at ESMO Immuno-Oncology Congress 2017

  ARMO BioSciences today announced additional clinical trial results on its lead investigational immuno-oncology drug AM0010 in metastatic renal cell carcinoma.

  December 8, 2017

   · 

  4 min read
• Business

  Synlogic and Ginkgo Bioworks Announce Collaboration as First Step Toward Building an Unprecedented Discovery Engine for Novel Living Medicines in Neurological and Liver Disorders

  Together, Synlogic and Ginkgo aim to transform the discovery and design of living medicines.

  December 8, 2017

   · 

  6 min read
• Pharm Country

  Impax Receives Tentative FDA Approval of Generic Coreg CR (Carvedilol Phosphate) Extended-Release Capsules

  The Company’s ANDA is eligible for final approval upon the expiration of marketing exclusivity on May 7, 2018.

  December 8, 2017

   · 

  5 min read
• Drug Development

  Encouraging Updated Results From Phase Ib/II Study Evaluating the Combination of Eribulin Mesylate and Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer Presented at the 2017 SABCS

  Findings presented during the 2017 SABCS showed the combination of eribulin and pembrolizumab resulted in an objective response rate of 26.4% the primary efficacy endpoint of the study.

  December 8, 2017

   · 

  10 min read
• 

  Sweden’s Active Biotech is Strapped for Cash and May Not Survive 2018

  The Board has also decided to sell the company’s property in Lund as a possible way of generating additional liquidity for the company.

  December 8, 2017

   · 

  2 min read